A practical guide for providers on helping patients access Ajovy. Covers specialty pharmacy routing, prior auth strategies, and financial assistance programs.
You've determined that Ajovy (Fremanezumab-vfrm) is the right choice for your patient's migraine prevention. But between specialty pharmacy logistics, insurance hurdles, and cost barriers, getting the medication into their hands can feel like a separate clinical challenge entirely.
This guide provides a practical, step-by-step approach for providers and clinical staff to streamline Ajovy access for patients — from initial prescribing through ongoing refill management.
As of early 2026, Ajovy is not in formal shortage. The drug is actively manufactured and distributed by Teva Pharmaceuticals. However, patient access challenges remain common due to:
Understanding these barriers allows your practice to proactively address them rather than reactively troubleshoot when patients call saying they can't get their medication.
The most common reasons patients report difficulty finding Ajovy:
Always send Ajovy prescriptions to a specialty pharmacy, ideally one within the patient's insurance network. Common specialty pharmacy partners include:
If you're unsure which specialty pharmacy a patient's plan prefers, Teva Shared Solutions (1-800-887-8100) can help identify the correct channel.
Pro tip: Build a reference list of preferred specialty pharmacies by major insurance plan. This saves time on every new Ajovy prescription.
Don't wait for the pharmacy to trigger a PA request. Submit prior authorization at the time of prescribing using CoverMyMeds (covermymeds.com or 1-866-452-5017) for electronic PA processing.
Ensure your PA request includes:
Strong documentation dramatically increases first-pass approval rates and reduces back-and-forth with insurance.
Address cost concerns before the patient encounters sticker shock:
Having this conversation early — ideally during the initial prescribing visit — prevents treatment abandonment due to unexpected costs.
Many patients have never used a specialty pharmacy before. Brief education can prevent confusion and missed doses:
Ajovy access isn't a one-time setup — it requires ongoing attention:
If Ajovy access remains problematic despite these steps, consider transitioning to an alternative CGRP inhibitor:
For detailed clinical comparisons, see: Ajovy Shortage: What Providers Need to Know in 2026.
Integrate these practices into your clinic workflow to reduce Ajovy access issues:
Getting patients started on Ajovy — and keeping them on it — requires more than just writing a prescription. The specialty pharmacy model, insurance requirements, and cost structure create real barriers that clinical teams need to actively manage.
By building systematic approaches to pharmacy routing, prior authorization, and financial assistance, your practice can significantly reduce the friction your patients face when accessing Ajovy for migraine prevention.
Visit Medfinder for Providers for real-time availability tools and additional prescriber resources.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
